Phosphodiesterases in heart and vessels-From Physiology to Diseases
Phosphodiesterases (PDEs) are a superfamily of enzymes that hydrolyze cyclic nucleotides,
including cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate …
including cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate …
Clinical pharmacology of cardiac cyclic AMP in human heart failure: too much or too little?
A Lymperopoulos - Expert Review of Clinical Pharmacology, 2023 - Taylor & Francis
ABSTRACT Introduction Cyclic 3', 5'-adenosine monophosphate (cAMP) is a major signaling
hub in cardiac physiology. Although cAMP signaling has been extensively studied in cardiac …
hub in cardiac physiology. Although cAMP signaling has been extensively studied in cardiac …
Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery
Restrictive cardiomyopathy (RCM) is defined as increased myocardial stiffness and impaired
diastolic relaxation leading to elevated ventricular filling pressures. Human variants in …
diastolic relaxation leading to elevated ventricular filling pressures. Human variants in …
A membrane-associated phosphoswitch in Rad controls adrenergic regulation of cardiac calcium channels
A Papa, PJ del Rivero Morfin, BX Chen… - The Journal of …, 2024 - Am Soc Clin Investig
The ability to fight or flee from a threat relies on an acute adrenergic surge that augments
cardiac output, which is dependent on increased cardiac contractility and heart rate. This …
cardiac output, which is dependent on increased cardiac contractility and heart rate. This …
A-kinase anchoring proteins in cardiac myocytes and their roles in regulating calcium cycling
H Subramanian, VO Nikolaev - Cells, 2023 - mdpi.com
The rate of calcium cycling and calcium transient amplitude are critical determinants for the
efficient contraction and relaxation of the heart. Calcium-handling proteins in the cardiac …
efficient contraction and relaxation of the heart. Calcium-handling proteins in the cardiac …
Interleukin 11 therapy causes acute left ventricular dysfunction
Abstract Aims Interleukin 11 (IL11) was initially thought important for platelet production,
which led to recombinant IL11 being developed as a drug to treat thrombocytopenia. IL11 …
which led to recombinant IL11 being developed as a drug to treat thrombocytopenia. IL11 …
Compartmentalized cAMP signalling and control of cardiac rhythm
J Tomek, M Zaccolo - Philosophical Transactions of the …, 2023 - royalsocietypublishing.org
In the last 30 years, the field of cyclic adenosine 3′, 5′-monophosphate (cAMP) signalling
has witnessed a transformative development with the realization that cAMP is …
has witnessed a transformative development with the realization that cAMP is …
Anchored PKA synchronizes adrenergic phosphoregulation of cardiac Cav1. 2 channels
L Wang, Y Chen, J Li, R Westenbroek, T Philyaw… - Journal of Biological …, 2024 - jbc.org
Adrenergic modulation of voltage gated Ca 2+ currents is a context specific process. In the
heart Ca v 1.2 channels initiate excitation–contraction coupling. This requires PKA …
heart Ca v 1.2 channels initiate excitation–contraction coupling. This requires PKA …
The C-terminus of Rad is required for membrane localization and L-type calcium channel regulation
G Elmore, BM Ahern, NM McVay, KW Barker… - Journal of General …, 2024 - rupress.org
L-type CaV1. 2 current (ICa, L) links electrical excitation to contraction in cardiac myocytes.
ICa, L is tightly regulated to control cardiac output. Rad is a Ras-related, monomeric protein …
ICa, L is tightly regulated to control cardiac output. Rad is a Ras-related, monomeric protein …
Divergent regulation of KCNQ1/E1 by targeted recruitment of protein kinase A to distinct sites on the channel complex
X Zou, SK Shanmugam, SA Kanner, KJ Sampson… - Elife, 2023 - elifesciences.org
The slow delayed rectifier potassium current, I Ks, conducted through pore-forming Q1 and
auxiliary E1 ion channel complexes is important for human cardiac action potential …
auxiliary E1 ion channel complexes is important for human cardiac action potential …